Skip to content

Ten-Year Outcomes of Posterior Scleral Contraction for Myopic Maculopathy: A Prospective Observational Study

Ten-Year Outcomes of Posterior Scleral Contraction for Myopic Maculopathy: A Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115279
Enrollment
Unknown
Registered
2025-12-24
Start date
2024-12-04
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopic Maculopathy

Interventions

Experiment Group(posterior scleral contraction group):None
Control Group(Non-posterior scleral contraction group):None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: This study included high myopia patients who attended the High Myopia Clinic of our hospital from January 2012 through December 2016. 1. Age>=18 years at follow-up, male or female; 2. Axial length >=26 mm or spherical equivalent refractive error >=-6.0 diopters; 3. Complete examination records at our hospital at the time of enrollment; 4. Able to cooperate with study examinations and procedures; 5. No history of ocular trauma or trauma-related surgery; 6. Able to understand the purpose of the study, voluntarily participate, and provide signed informed consent by the patient or legal guardian.

Exclusion criteria

Exclusion criteria: 1. History of ocular trauma or trauma-related ocular surgery; 2. Presence of other vision-impairing ocular diseases (e.g., glaucoma, diabetic retinopathy, corneal opacity); 3. Incomplete medical records or examination data; 4. Inability to cooperate with study examinations due to mental disorders or other reasons; 5. Pregnant or breastfeeding women; 6. Long-term use of ocular or systemic medications that may affect visual outcomes; 7. Any other condition that, in the judgment of the investigator, would make the participant unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
The rate of myopic maculopathy progression;

Secondary

MeasureTime frame
Axial Length;Foveal thickness;Best-Corrected Visual Acuity (BCVA);Intraocular pressure;

Countries

China

Contacts

Public ContactHuifang Ye

Eye Hospital, Wenzhou Medical University

yehuifang@wmu.edu.cn+86 136 5650 7536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026